Methods and compositions for treatment of cell proliferative disorders
Abstract
The invention relates to methods and compositions, and compositions at least comprises a endothelin antagonist, the is preferably designed with is β -1,4-N- acetyl glucosamine (p-GlcNAc) polysaccharide matrix combined to the other cancers and hyperphasia diseases' compositions. The endothelin antagonists can be peptide And Huo non-peptide compounds, the p-GlcNA in the invention comprises a macromolecular weight polymer, wherein monosaccharide component is β -1,4 are connected, and are monosaccharide and) respectively comprises a protein, basically and a single amino acid, does not contain the organic and inorganic discharging. The compositions and methods of the invention can be used for inhibiting the growth of the tumours and lump cells, and/or a restraining body lump the transfusion.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
80 members in 17 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 21828898 | United States of America | A | |
| 9930575 | United States of America | W |
Members80
| Document | Office | Kind | |
|---|---|---|---|
| IL111825D0 | Israel | D0 | |
| CA2177823A1 | Canada | A1 | |
| CA2372026A1 | Canada | A1 | |
| CA2604073A1 | Canada | A1 | |
| WO9515343A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1296995A | Australia | A | |
| EP0731812A1 | European Patent Office (EPO) | A1 | |
| WO9639122A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5917896A | Australia | A | |
| CN1142833A | China | A | |
| US5622834A | United States of America | A | |
| US5623064A | United States of America | A | |
| US5624679A | United States of America | A | |
| US5635493A | United States of America | A | |
| JPH09506126A | Japan | A | |
| EP0731812A4 | European Patent Office (EPO) | A4 | |
| US5686115A | United States of America | A | |
| NZ277662A | New Zealand | A | |
| AU695850B2 | Australia | B2 | |
| US5846952A | United States of America | A | |
| US5858350A | United States of America | A | |
| US6063911A | United States of America | A | |
| CA2356087A1 | Canada | A1 | |
| WO0036918A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2591900A | Australia | A | |
| WO0036918A9 | World Intellectual Property Organization (WIPO) | A9 | |
| NO20013071D0 | Norway | D0 | |
| NO20013071L | Norway | L | |
| EP1139752A1 | European Patent Office (EPO) | A1 | |
| TW458987B | Taiwan Province of China | B | |
| US2001055807A1 | United States of America | A1 | |
| CN1335749A | China | A | |
| IL143700D0 | Israel | D0 | |
| CA2177823C | Canada | C | |
| US2002091101A1 | United States of America | A1 | |
| US2002098579A1 | United States of America | A1 | |
| US2002106792A1 | United States of America | A1 | |
| HK1043507A1 | Hong Kong, China | A1 | |
| EP1139752A4 | European Patent Office (EPO) | A4 | |
| JP2003522732A | Japan | A | |
| US6599720B2 | United States of America | B2 | |
| US6610668B2 | United States of America | B2 | |
| US6630459B2 | United States of America | B2 | |
| US2003212040A1 | United States of America | A1 | |
| US6649599B2 | United States of America | B2 | |
| NZ512586A | New Zealand | A | |
| US6686342B2 | United States of America | B2 | |
| EP0731812B1 | European Patent Office (EPO) | B1 | |
| AT263785T | Austria | T | |
| ATE263785T1 | Austria | T1 | |
| US2004087015A1 | United States of America | A1 | |
| DE69433692D1 | Germany | D1 | |
| US6743783B1 | United States of America | B1 | |
| JP2004211101A | Japan | A | |
| DK0731812T3 | Denmark | T3 | |
| PT731812E | Portugal | E | |
| EP1452546A2 | European Patent Office (EPO) | A2 | |
| EP1452546A3 | European Patent Office (EPO) | A3 | |
| ES2219659T3 | Spain | T3 | |
| US2005004072A1 | United States of America | A1 | |
| US6864245B2 | United States of America | B2 | |
| AU780248B2 | Australia | B2 | |
| DE69433692T2 | Germany | T2 | |
| EP1139752B1 | European Patent Office (EPO) | B1 | |
| AT294504TThis record | Austria | T | |
| ATE294504T1 | Austria | T1 | |
| DE69925156D1 | Germany | D1 | |
| ES2242448T3 | Spain | T3 | |
| DE69925156T2 | Germany | T2 | |
| IL143700A | Israel | A | |
| US2007105815A1 | United States of America | A1 | |
| JP3993633B2 | Japan | B2 | |
| CA2356087C | Canada | C | |
| JP2009079223A | Japan | A | |
| CN100488512C | China | C | |
| US2009247738A1 | United States of America | A1 | |
| HK1043507B | Hong Kong, China | B | |
| CN1142833B | China | B | |
| NO330033B1 | Norway | B1 | |
| JP4795539B2 | Japan | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 99968523
Titles2
- German
- VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON ZELLPROLIFERATIONSSTÖRUNGEN
- English
- METHOD AND COMPOSITIONS FOR TREATING CELL-TYPING TROUBLE SHOOTING
Classification
- CPC, 7
- C08B37/003
- A61K31/785
- A61L31/042
- A61P35/00
- C12N2533/70
- A61P43/00
- C12P19/26
- IPC, 11
- C07D401 14
- A61K31 506
- A61K31 785
- A61K38 00
- A61K45 00
- A61K47 36
- A61L31 04
- A61P35 00
- A61P43 00
- C08B37 08
- C12P19 26